Doramectin Injection

Doramectin Injection

  • Packing: 10 ml, 20 ml, 50 ml Vial
  • Available Strength : 10 Mg/Ml

Description

Product Description: Doramectin Injection is a sterile solution containing doramectin, a broad-spectrum antiparasitic medication. It is intended for subcutaneous administration to cattle and swine. Doramectin belongs to the avermectin class of compounds, which are highly effective against a wide range of internal and external parasites.

Indications and Usage: Doramectin Injection is indicated for the treatment and control of internal and external parasites in cattle and swine. It is effective against gastrointestinal roundworms, lungworms, mites, lice, and mange in cattle, and gastrointestinal roundworms, lungworms, kidney worms, mange, lice, and mites in swine.

Dosage and Administration: The recommended dosage of Doramectin Injection varies depending on the species of animal being treated and the severity of the parasitic infection. It is typically administered as a single subcutaneous injection at a dose of 200 μg/kg body weight in cattle and 300 μg/kg body weight in swine.

Dosage Forms and Strengths: Doramectin Injection is available as a sterile solution in vials or ampules. The strength of the solution is typically expressed in micrograms of doramectin per milliliter (μg/mL), with various concentrations available to accommodate different dosing regimens.

Contraindications: Doramectin Injection is contraindicated in animals with known hypersensitivity to doramectin or any component of the formulation. It should not be used in animals intended for human consumption within a certain withdrawal period, as specified in the product labeling.

Warnings and Precautions: Use caution when administering Doramectin Injection in debilitated or severely ill animals, as safety in these populations has not been established. Do not overdose, as excessive dosages may result in adverse reactions. Avoid accidental self-injection, and wash hands thoroughly after handling the product.

Adverse Reactions/Side Effects: Common adverse reactions associated with Doramectin Injection may include transient local irritation or inflammation at the injection site, hypersalivation, diarrhea, and lethargy. Rare but serious adverse reactions may include allergic reactions (such as itching, hives, or swelling) and neurologic signs (such as tremors or ataxia).

Drug Interactions: There are no known drug interactions with Doramectin Injection. However, caution should be exercised when administering other medications concurrently, as the safety and efficacy of concurrent therapy have not been established.

Use In Specific Populations Description: Safety and efficacy of Doramectin Injection in pregnant or lactating animals have not been established. Use caution and consult with a veterinarian before administering Doramectin Injection to animals in these populations.

How Supplied/Storage and Handling: Doramectin Injection is supplied as a sterile solution in vials or ampules for subcutaneous administration. It should be stored at controlled room temperature (20°C to 25°C) away from light and moisture. Care should be taken to ensure proper storage and handling to maintain the integrity of the product. Unused portions should be discarded according to standard procedures for biohazardous waste.